Abcodia Suspends Sale of Ovarian Cancer Screening Test After FDA Communication

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Abcodia Inc., a British company that manufactures a controversial ovarian cancer screening test, said it will temporarily suspend the availability of the product in the United States.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Laura Brawley
Laura Brawley
Table of Contents

YOU MAY BE INTERESTED IN

Laura Brawley
Laura Brawley

Login